Global pharma major Pfizer has said its COVID-19 vaccine is being priced in a way that will help governments to ensure that there is little to no out-of-pocket costs for their people, as it seeks to ensure access to the vaccine across the world. For this pandemic period, the company s pricing approach is based on the principle of ensuring broad access and supplies to the governments, a Pfizer spokesperson said in a statement. The company s decision-making is not being driven by traditional cost/benefit analysis,it added. Our pricing strategy is an outcome of volume, advanced commitment, equity and affordability principles. We are pricing in a way that can help governments to ensure that there is little to no out-of-pocket costs for their populations.
Synopsis
The company also said governments globally are developing comprehensive and strategic pandemic response plans. At this time, it is most appropriate that any vaccine that receives regulatory approval is made available to governments for use as per their plan.
Reuters
NEW DELHI: Global pharma major
Pfizer has said its COVID-19 vaccine is being priced in a way that will help governments to ensure that there is little to no out-of-pocket costs for their people, as it seeks to ensure access to the vaccine across the world. For this pandemic period, the company s pricing approach is based on the principle of ensuring broad access and supplies to the governments, a Pfizer spokesperson said in a statement.
COVID-19 vaccine pricing to help Govts to ensure little to no out-of-pocket costs for people: Pfizer
NEW DELHI, Dec 17:Global pharma major Pfizer has said its COVID-19 vaccine is being priced in a way that will help governments to ensure that there is little to no out-of-pocket costs for their people, as it seeks to ensure access to the vaccine across the world.
For this pandemic period, the company’s pricing approach is based on the principle of ensuring broad access and supplies to the governments, a Pfizer spokesperson said in a statement.
The company’s decision-making is not being driven by traditional cost/benefit analysis, it added.
NEW DELHI: Global pharma major Pfizer has said its Covid-19 vaccine is being priced in a way that will help governments to ensure that there is little to no out-of-pocket costs for their people, as it seeks to ensure access to the vaccine across the world.
For this pandemic period, the company s pricing approach is based on the principle of ensuring broad access and supplies to the governments, a Pfizer spokesperson said in a statement.
The company s decision-making is not being driven by traditional cost/benefit analysis, it added. Our pricing strategy is an outcome of volume, advanced commitment, equity and affordability principles. We are pricing in a way that can help governments to ensure that there is little to no out-of-pocket costs for their populations.
COVID vaccine pricing to help governments to ensure little to no out-of-pocket costs for people: Pfizer
For this pandemic period, the company s pricing approach is based on the principle of ensuring broad access and supplies to the governments, a Pfizer spokesperson said in a statement.
Share Via Email
| A+A A- By PTI
NEW DELHI: Global pharma major Pfizer has said its COVID-19 vaccine is being priced in a way that will help governments to ensure that there is little to no out-of-pocket costs for their people, as it seeks to ensure access to the vaccine across the world.
For this pandemic period, the company s pricing approach is based on the principle of ensuring broad access and supplies to the governments, a Pfizer spokesperson said in a statement.